Progress towards safer and more effective radical cure of Plasmodium vivax

Progress towards safer and more effective radical cure of Plasmodium vivax

Plasmodium vivax causes a substantial burden of disease in the Americas, the Horn of Africa, and Asia-Pacific. The parasite forms dormant liver stages (hypnozoites) that reactivate weeks to months after an initial infection causing recurrent episodes of malaria (relapses). Multiple recurrences are a...

Detaylı Bibliyografya
Yazar:	Price, RN
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2024

Benzer Materyaller

Expanding the use of primaquine for the radical cure of Plasmodium vivax
Yazar:: Price, RN, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Improving the radical cure of Plasmodium vivax malaria.
Yazar:: Price, R
Baskı/Yayın Bilgisi: (2014)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
Yazar:: Rahmalia, A, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
Yazar:: Kamala Thriemer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Single-dose radical cure of Plasmodium vivax: a step closer.
Yazar:: Price, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Single-dose radical cure of Plasmodium vivax: A step closer
Yazar:: Price, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
Yazar:: John, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Primaquine radical cure of <it>Plasmodium vivax</it>: a critical review of the literature
Yazar:: John George K, ve diğerleri
Baskı/Yayın Bilgisi: (2012-08-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
Yazar:: Watson, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Global economic costs due to Plasmodium Vivax malaria treatment and the cost-benefit of radical cure
Yazar:: Devine, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
Yazar:: Rahmalia, A, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
Yazar:: Abla, N, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
Yazar:: Nada Abla, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Cost-effectiveness analysis of gender-stratified Plasmodium vivax treatment strategies using available g6pd diagnostics to accelerate access to radical cure
Yazar:: Devine, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
Yazar:: Kamala Thriemer, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Yazar:: Taylor, WRJ, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
Yazar:: Watson, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
Yazar:: Thanh Vinh Pham, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
Yazar:: Markus MB
Baskı/Yayın Bilgisi: (2021-09-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
Yazar:: James A Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
Yazar:: Yilma, D, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
Yazar:: Walter R J Taylor, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
Yazar:: Annisa Rahmalia, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Treatment algorithms with radical cure of vivax malaria based on sex: a cost-effectiveness analysis to support roll out strategies
Yazar:: Devine, A, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
Yazar:: Jasmine M. Olvany, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Yazar:: James A Watson, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Strategies for improving radical cure in P. vivax malaria
Yazar:: John, G
Baskı/Yayın Bilgisi: (2012)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Yazar:: Taylor, WRJ, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
Yazar:: Pukrittayakamee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Yazar:: Raman Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study
Yazar:: Soy Ty Kheang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Yazar:: Soy Ty Kheang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
Yazar:: Ruwanpura, VSH, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
Yazar:: Yilma, D, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Evidence uptake is only part of the process: stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria
Yazar:: Ruwanpura, VSH, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
Yazar:: Devine, A, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro
Yazar:: Maher, SP, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro
Yazar:: Steven P. Maher, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials
Yazar:: R.J. Commons, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
Yazar:: Sadhewa, A, ve diğerleri
Baskı/Yayın Bilgisi: (2023)